NCT04381390 is a NA clinical trial of Whole egg and resistance training in Hypertrophy, sponsored by Alexei Wong.

Who is sponsoring NCT04381390?

NCT04381390 is sponsored by Alexei Wong.

What drugs are being tested in NCT04381390?

Interventions in NCT04381390: Whole egg and resistance training, Egg whites and resistance training.

What condition does NCT04381390 study?

NCT04381390 studies Hypertrophy.

Is NCT04381390 still recruiting?

NCT04381390 is currently completed. Last updated 8 May 2020.

Last reviewed 2020-05-08 · How we verify

NCT04381390

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Egg Consumption and Muscular Adaptations

Completed NA Last updated 8 May 2020

What this trial tests

NA trial testing Whole egg and resistance training in Hypertrophy in 30 participants. Completed in 2 October 2019.

Timeline

10 September 2018

Primary endpoint
2 October 2019

2 October 2019

Quick facts

Lead sponsor	Alexei Wong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	30
Start date	10 September 2018
Primary completion	2 October 2019
Estimated completion	2 October 2019
Sites	1 location across United States

Drugs / interventions tested

Whole egg and resistance training
Egg whites and resistance training

Conditions studied

Hypertrophy — all drugs for Hypertrophy →

Sponsor

Alexei Wong

Who can join

Adults 18 to 30, male only, with Hypertrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Eggs may be a viable alternative to various types of supplemental proteins given its similar ratings on various measures of dietary protein quality. The investigators hypothesis is that whole eggs would create a greater improvement in skeletal regulatory markers, hormonal responses and body composition than egg white ingestion in resistance-trained men.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertrophy

Currently open trials in the same condition.

NCT06573086 — Resistance Training, Detraining, and Retraining Study 2024 (TraDeRe2024) · NA · recruiting
NCT05774444 — Investigating the Effects of Krill Oil and Krill Protein on Post-exercise Muscle Protein Metabolism · NA · recruiting
NCT04514744 — Dynamic Proteomics and Integrated Rates of Muscle Protein Synthesis During an Acute Period of Loading and Unloading · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04381390 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexei Wong
Last refreshed: 8 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04381390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing